Unknown PHASE2 INTERVENTIONAL 2-arm NCT03280407

NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer (NEOLAR)

NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer: a Randomized Phase II Trial

Sponsor: Zealand University Hospital

Conditions Chemotherapy Effect Colorectal Cancer Colorectal Neoplasm Intestinal Disease Intestinal Neoplasms Rectal Cancer Rectal Neoplasms

Interventions CAPOX (oxaliplatin/capecitabine) Capecitabine FOLFOX regimen (oxaliplatin/leucovorin/5FU)

Updated 6 times since 2017 Last updated: Sep 26, 2017 Started: Mar 1, 2017 Primary completion: Dec 31, 2018 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Chemotherapy Effect and Colorectal Cancer and is currently ongoing. Zealand University Hospital leads this study, which shows 6 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Feb 2025 — Present [monthly]

Unknown PHASE2

Status: Recruiting → Unknown
Sep 2024 — Feb 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jan 2021 — Jul 2024 [monthly]

Recruiting PHASE2
Jun 2018 — Jan 2021 [monthly]

Recruiting PHASE2

▶ Show 1 earlier version

Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zealand University Hospital

Data source: Zealand University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vejle, Denmark